T1	p 51 82	adults with autistic disorder .
T2	p 233 272	adult patients with autistic disorder .
T3	p 281 405	Twenty drug-free adults with autistic disorder ( 16 men and 4 women ) ( mean [ +/- SD ] age , 30.5 +/- 8.5 years ) underwent
T4	p 2117 2139	patients with autism .
T5	p 2287 2295	patients
T6	i 458 476	placebo-controlled
T7	i 529 609	24-hour , low-tryptophan diet followed the next morning by an amino acid drink .
T8	i 665 675	amino acid
T9	i 1298 1304	pacing
T10	i 1307 1314	banging
T11	i 1319 1331	hitting self
T12	i 1348 1351	toe
T13	i 1652 1678	tryptophan-deficient amino
T14	o 168 189	biochemical responses
T15	o 610 628	Behavioral ratings
T16	o 745 784	Plasma free and total tryptophan levels
T17	o 1005 1064	worsening of behavioral symptoms with short-term tryptophan
T18	o 1138 1153	clinical status
T19	o 1255 1361	in behaviors such as whirling , flapping , pacing , banging and hitting self , rocking , and toe walking (
T20	o 1421 1454	calm and happy and more anxious .
T21	o 1470 1476	change
T22	o 1493 1589	social relatedness or repetitive thoughts and behavior . Plasma total and free tryptophan levels
T23	o 1730 1754	exacerbation of symptoms
T24	o 1780 1819	baseline plasma total tryptophan levels
T25	o 1837 1869	Autism Behavior Checklist scores
T26	o 1937 1945	symptoms